Published on
14:13 GMT
Palivizumab for Severe Respiratory Syncytial Virus Infection in Immunocompetent Adults: A Case Series
Introduction Respiratory syncytial virus (RSV) is a major cause of respiratory illness globally, responsible for significant morbidity and mortality in both infants and adults. While RSV is well-recognized as a leading cause of bronchiolitis and pneumonia …
Source:
Dove Medical Press
-
Neutral
